Since investment bank HSBC…
Since investment bank HSBC downgraded the stock of Eli Lilly [...]
Since investment bank HSBC downgraded the stock of Eli Lilly [...]
According to a review by The New York Times, the [...]
The once-daily pill stands to shake up the injectable-filled psoriasis [...]
Indiana’s governor Mike Braun aims to create 100,000 “high wage” [...]
More than 20 years after gaining FDA approval for Flovent, [...]
While BioMarin has been focusing heavily on its CNP analogue, [...]
Amgen’s Amjevita, Aimovig and Repatha—plus GSK’s Ellipta inhalers and its [...]
Idorsia is gearing up for another CEO change with the [...]
The CEO’s 2025 pay was a sizeable bump over the [...]
GSK has secured an FDA expansion for its respiratory syncytial [...]